Featured Insights
November 10, 2025
Article
Software is a key value driver in M&A transactions. In M&A Review, Latham partners Susan Kempe-Müller and Christina Mann discuss what sellers and buyers should focus on (in German).
November 10, 2025
Client Alert
With new draft guidance, FDA continues prior efforts to reduce the need for comparative clinical studies in biosimilar development and speed new products to market.
November 6, 2025
Podcast
Explore how stablecoins are reshaping the financial landscape and the distinct regulatory approaches in the US, EU, and UK that are influencing their development.